Skip to main content
. Author manuscript; available in PMC: 2017 Aug 23.
Published in final edited form as: Mol Pharm. 2013 Jul 30;10(9):3514–3518. doi: 10.1021/mp400164f

Figure 4.

Figure 4

Western blotting data with cell viability (grey bars) and % expression of eIF4E/ actin (white bars) of MDA-MB-231 cells at 48 hr, a; 1DHFR2RGD4C, b; 13DHFR2RGD4C, c; Bis-MTX-ASO, d; 1.0 μM multimer scrambled, e; 1.0 μM monomer scrambled, f; 1.0 μM ASO with Oligofectamine, g; 1.0 μM multimer, h; 1.0 μM monomer, i. (* p > 0.01)